Serena Camilla Dalto, MD^1*, Antonella Romanelli, MD^2*, Martina Violati, MD^2*, Martina Zucca, DR^3*, Fiammetta Ferrandi, Mrs^2*, Carlotta Galeone, DR^4*, Carmelo Carlo-Stella, Prof MD^5,6,7, Mauro Moroni, MD^3* and Vittorio Montefusco, MD^2*

¹Hematology, ASST Santi Paolo e Carlo, Milan, ITA
²Hematology, ASST Santi Paolo e Carlo, Milan, Italy
³Oncology, ASST Santi Paolo e Carlo, Milan, Italy
⁴Bicocca Applied Statistics Center (B ASC), Universita degli Studi di Milano-Bicocca, Milan, Italy
⁵Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
⁶Humanitas Cancer Center, Rozzano, Milano, ITA
⁷IRCCS Humanitas Research Hospital, Humanitas University, ROZZANO, ITA

Rahul Banerjee, MD^1,2, Gurbakhash Kaur, MD, MA³, Bo Wang, MD^4*, Larry D. Anderson Jr., MD, PhD³, Georgia McCaughan, MBBS, MMed^5,6*, Andrew J. Cowan, MD^1,2 and S. Vincent Rajkumar, MD^7*

¹University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA
³Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁴Willamette Valley Cancer Institute and Research Center, Eugene, OR
⁵Department of Haematology, St. Vincent's Hospital, Sydney, Australia
⁶University of New South Wales, Garvan Institute of Medical Research, Sydney, Australia
⁷Mayo Clinic, Rochester, MN

Sikander Ailawadhi¹, Shelby Sullivan, PharmD^2*, Jeffrey Carter, PhD^3* and Cherilyn Heggen, PhD^3*

¹Mayo Clinic, Jacksonville, FL
²PRIME Education, LLC, Berkley, MI
³PRIME Education, LLC, Fort Lauderdale, FL

Jonas Paludo, MD¹, Radhika Bansal, MBBS^2*, Matthew Hathcock^1*, Joshua C Pritchett, MD^1*, Andre De Menezes Silva Corraes, MD^2*, Beatriz A Oyarzabal^1*, William S Harmsen, MS^1*, Julianne J Lunde^1*, Jordan D Coffey^1*, Kelsey L Haugen^1*, Megan Spychalla^1*, Arushi Khurana, MBBS¹, Hassan Alkhateeb, MD^1*, David Dingli, MD¹, Suzanne R. Hayman, MD¹, Prashant Kapoor, MD¹, Morie A Gertz, MD^1*, Yucai Wang, MD, PhD¹, Moritz Binder, MD¹, Paul J. Hampel, MD¹, Saad S. Kenderian, MD¹, Taxiarchis Kourelis, MD³, Shaji Kunnathu Kumar, MD³, Mithun V Shah, MD, PhD³, Mustaqeem A Siddiqui, MD^1*, Rahma M Warsame, MD¹, Jose. C. Villasboas, MD^1*, N. Nora Bennani, MD¹, Patrick B Johnston, MD, PhD^1*, Stephen M Ansell, MD, PhD¹, Tufia C Haddad, MD^1* and Yi Lin, MD, PhD²

¹Mayo Clinic, Rochester, MN
²Mayo Clinic Cancer Center, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN

Maurlia Upchurch, PharmD^1*, Stephanie B Wheeler^2*, Leah Zullig, Ph.D.^3*, Jennifer Elston Lafata, Ph.D.^4* and Benyam Muluneh, PharmD^5,6

¹Department of Pharmacology and Therapeutics, UNC Chapel Hill, Durham, NC
²University of North Carolina, Chapel Hill, NC
³Duke Cancer Institute, Durham
⁴University of North Carolina Chapel Hill, Chapel Hill
⁵University of North Carolina, Lineberger Cancer Center, Chapel Hill, NC
⁶UNC Chapel Hill, Chapel Hill, NC

Gaurav Agarwal, MD^1*, Lauren Campbell, PhD^2*, Oluremi Carty^2*, Sally Moore^3*, Sarah Gooding^4,5,6*, Jaimal Kothari^5,6*, Julia Evans^5*, Jemma Larham^5*, Lisa Ferguson^5*, Pamela Roberts^5*, Elizabeth Bateman^2*, Ross Sadler^2* and Karthik Ramasamy^5,6

¹MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Wraysbury, ENG, United Kingdom
²Immunology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
³Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
⁴MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
⁵Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁶Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom

Thomas G. Knight, MD¹, Danielle Boselli, MS^2*, Allison Verbyla, MPH^2*, Jing Ai, MD, PhD¹, Aleksander L. Chojecki, MD¹, Nilay Shah, MD^1*, Yifan Pang, MD¹, Lawrence J. Druhan, PhD¹, Edward A. Copelan, MD¹, Michael R. Grunwald¹ and Brittany Knick Ragon, MD¹

¹Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
²Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC

Rola Ghasoub, B.Sc. (Pharm), BCOP^1*, Shereen Elazzazy, PhD, MBA, Pharm D, B.Sc. (Pharm)^1*, Maria Benkhadra, Pharm D, B.Sc.(Pharm)^1*, Nancy Kassem, MSc (Pharm), B.Sc.(Pharm)^1*, Honar Cherif, MD PhD Professor^2*, Javid Gaziev, MD.PhD^2*, Hesham Elsabah, MD^2* and Anas Ahmad Hamad, PhD, MSc, B.Sc. (Pharm)^1*

¹Department of Pharmacy, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
²Hematology /BMT Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Vivek Patel, MD, Katherine Baker, MD^*, Danielle Fishman, MD^*, Spencer Lessans, MD^*, Trent Morris^*, Bhagirathbhai Dholaria, MBBS, Reena Jayani, MD, Adetola A. Kassim, MBBS, MS, Tae Kon Kim, MD, David Morgan, MD^*, Olalekan O. Oluwole, MBBS, Bipin N. Savani, MD, Salyka M. Sengsayadeth, MD^* and Shakthi Bhaskar, MD

Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN

Lauren C. Peres, PhD, MPH^1*, Pallavi Patwardhan, PhD, BSPharm^2*, David Huggar, PharmD, MS^2*, Gabriel De Avila, BS^1*, Laura B. Oswald, PhD^3*, Ariel F. Grajales-Cruz, MD⁴, Brandon Blue, MD⁵, Julieta Abraham Miranda, PhD^1*, Kayla Reid, MS^1*, Hien Liu, MD¹, Taiga Nishihori, MD⁶, Kenneth H. Shain, MD, PhD¹, Rachid Baz, MD⁴, Melissa Alsina, MD^1*, Omar Castaneda, MD⁷, Frederick L. Locke, MD¹, Ciara Louise L. Freeman, MD, PhD, MSc⁷, Simrandeep Tiwana, PhD, MBA^2*, Afraim Botros, PharmD, RPh^2* and Doris K. Hansen, MD^1*

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Bristol Myers Squibb, Princeton, NJ
³Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
⁴H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁷Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Olalekan O. Oluwole, MBBS¹, Markqayne D Ray, PharmD^2*, Richard Zur, PhD^3*, Aurelia Little^3*, Cheryl Ferrufino, BA^3*, Brett Doble, PhD^2*, Anik R Patel, PhD^2* and Pinar Bilir, MS^4*

¹Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
²Kite, A Gilead Company, Santa Monica, CA
³IQVIA, Falls Church, VA
⁴IQVIA, San Francisco, CA

Doris K. Hansen, MD¹, Xiaoxiao Lu^2*, Omar Castaneda, MD³, Sonja Sorensen^4*, Saad Z Usmani, MD⁵, Eileen Zhang^4*, Stephen Huo^2* and Sundar Jagannath, MD⁶

¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
²Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Evidera, Bethesda, MD
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

Ashley C. Saunders^1*, Tavneet Singh^2*, Abraham Lee^2*, Thalia Farazi³, Omotayo Fasan¹, Sana Mirza^2* and November McGarvey^2*

¹Bristol Myers Squibb, Princeton, NJ
²BluePath Solutions, Los Angeles, CA
³Bristol Myers Squibb, San Francisco, CA

Beenish S Manzoor, PhD, MPH^1*, Scott F. Huntington, MD, MPH, MSc², Dureshahwar Jawaid^1*, Justin T. Puckett, BA^3*, Nnadozie Emechebe^1*, Arliene Ravelo, MPH^4*, Sachin Kamal-Bahl^3* and Jalpa A. Doshi^5*

¹AbbVie Inc., North Chicago, IL
²Yale University, New Haven, CT
³COVIA Health Solutions, Lansdale, PA
⁴Genentech Inc., South San Francisco, CA
⁵University of Pennsylvania, Philadelphia, PA

Edward R Scheffer Cliff, MBBS, MPH¹, Mark McGuire^1*, Ghulam Rehman Mohyuddin, MD², Aaron Seth Kesselheim, MD, JD, MPH^1* and William B Feldman, MD, PhD, MPH^1*

¹Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Rahul Banerjee^1*, Nina Kim^2*, Monal Kohli^3*, Laura Hester^4*, Emily Achter^3*, Jessica Fowler, PhD^5*, Emeka Umeh^3*, Dee Lin^2*, Gideon Aweh^3*, Dina Gifkins^6*, Sian Walker^7* and Bingcao Wu^2*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Janssen Scientific Affairs, LLC, Horsham, PA
³STATinMED LLC, Dallas, TX
⁴Janssen R&D, LLC, Horsham, PA
⁵Johnson & Johnson, Horsham, PA
⁶Janssen R&D, LLC, Titusville, NJ
⁷Sierra Medical Affairs, LLC, Truckee, CA

YoungJu PARK^1,2*, Juhee Cho, PhD^2*, Sooyeon Kim^2*, Kihyun Kim, MD, PhD³, Sang Eun Yoon, MD., PhD^4*, Danbee Kang, PhD^2*, Garam Bang^5*, Nayeon Kim^6*, Jeong Hyun Park^2* and Seok Jin Kim, MD, PhD⁷

¹Medical Affairs, Janssen Korea Ltd., Seoul, Korea, Republic of (South)
²Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea, Republic of (South)
³Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁵Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁶Cancer Education Center, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁷Samsung Med. Ctr., Seoul, Korea, Republic of (South)

Tingting Qu, PhD^1*, Monika Jun, MPH^2*, Anindit Chhibber, PhD^2*, Alex Mutebi, PhD^2*, Huimin Li, PhD^3*, Yang Meng, PhD^1* and Anthony Wang, MPH, PhD^4*

¹Lumanity, Bethesda, MD
²Genmab US, Inc., Plainsboro, NJ
³AbbVie Inc., North Chicago, IL
⁴AbbVie, Inc., Chicago, IL

Santiago Riviello-Goya, MD¹, Analy Mora^2*, Daniela Vieyra Santiago, MD^1*, Akari Erandi Chávez Coronel^3*, Fausto Alfredo Rios Olais⁴, Gladys Patricia Agreda-Vásquez, MD^1*, Elena Juventina Tuna Aguilar, MD^1*, Elia Ixel Apodaca Chavez, MD^1*, Alvaro Aguayo, MD¹ and Roberta Demichelis, MD¹

¹Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
²Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad Hidalgo, Mexico
³Universidad Michoacana de San Nicolás de Hidalgo, Michoacan, Mexico
⁴Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico